Amy Nation, DO
Family Medicine · Oviedo, FLNPI 1124001326
Payments from drug & device makers
Across 65 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$184
- Pfizer$98
- Lilly USA, LLC$85
- AstraZeneca$79
- Merck$66
- GSK$61
- plus $619 from 23 others
What the payments were for
- Food & beverage$1,14296%
- Education$504%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 9 | $184 |
| Pfizer | 4 | $98 |
| Lilly USA, LLC | 5 | $85 |
| AstraZeneca | 5 | $79 |
| Merck | 5 | $66 |
| GSK | 4 | $61 |
| Johnson & Johnson(2 entities) | 4 | $60 |
| Novartis | 2 | $39 |
| Renalytix AI, Inc. | 2 | $38 |
| Bayer | 2 | $38 |
| Exact Sciences | 2 | $37 |
| Novo Nordisk | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Amgen | 2 | $32 |
| Averitas Pharma Inc. | 1 | $30 |
| Photonicare Inc | 1 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Abbott | 1 | $21 |
| IBSA Pharma Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Tolmar, Inc. | 1 | $18 |
| Vistapharm, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $13 |
How this compares
$1,192 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spiriva HandihalerTiotropium Bromide | 11 | $6,084 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $1,912 |
| Celecoxib | 14 | $1,693 |
| SynthroidLevothyroxine Sodium | 23 | $1,480 |
| UnithroidLevothyroxine Sodium | 16 | $1,118 |
| Risedronate Sodium | 13 | $1,019 |
| Zolpidem Tartrate | 54 | $977 |
| Bupropion XlBupropion Hcl | 24 | $749 |
| Atorvastatin Calcium | 80 | $747 |
| Fluticasone Propionate | 29 | $722 |
| Duloxetine Hcl | 28 | $722 |
| Pantoprazole Sodium | 42 | $677 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $614 |
| Simvastatin | 64 | $512 |
| Cyclobenzaprine Hcl | 17 | $495 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $184 | $1,48023 claims |
| Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium | $22 | $1,33347 claims |
| PfizerLevoxyl | $98 | $42011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Oviedo
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.